[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biosimilars-On-Biologics Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

October 2023 | 111 pages | ID: GE6F696DE767EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question


There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of these life saving drugs. However, these possibilities are opposed by some scientific challenges and unanswered questions.


The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Biosimilars-On-Biologics market covering all its essential aspects.



For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.



In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.



Key players in the global Biosimilars-On-Biologics market are covered in Chapter 9:

Biogen idec Inc.
Teva Pharmaceutical Industries Ltd.
LG Life Sciences
Synthon Pharmaceuticals, Inc.
Novartis
Hospira
Merck Serono
Celltrion
Biocon


In Chapter 5 and Chapter 7.3, based on types, the Biosimilars-On-Biologics market from 2017 to 2027 is primarily split into:

Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide


In Chapter 6 and Chapter 7.4, based on applications, the Biosimilars-On-Biologics market from 2017 to 2027 covers:

Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies


Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa



Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Biosimilars-On-Biologics market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Biosimilars-On-Biologics Industry.



2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.



3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.



Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.



4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.



Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.



Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.



Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.



Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.



Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.



Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.



Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.



Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.



Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.



Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.



Chapter 11 introduces the market research methods and data sources.



Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2027

1 BIOSIMILARS-ON-BIOLOGICS MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilars-On-Biologics Market
1.2 Biosimilars-On-Biologics Market Segment by Type
  1.2.1 Global Biosimilars-On-Biologics Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Biosimilars-On-Biologics Market Segment by Application
  1.3.1 Biosimilars-On-Biologics Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Biosimilars-On-Biologics Market, Region Wise (2017-2027)
  1.4.1 Global Biosimilars-On-Biologics Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Biosimilars-On-Biologics Market Status and Prospect (2017-2027)
  1.4.3 Europe Biosimilars-On-Biologics Market Status and Prospect (2017-2027)
  1.4.4 China Biosimilars-On-Biologics Market Status and Prospect (2017-2027)
  1.4.5 Japan Biosimilars-On-Biologics Market Status and Prospect (2017-2027)
  1.4.6 India Biosimilars-On-Biologics Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Biosimilars-On-Biologics Market Status and Prospect (2017-2027)
  1.4.8 Latin America Biosimilars-On-Biologics Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Biosimilars-On-Biologics Market Status and Prospect (2017-2027)
1.5 Global Market Size of Biosimilars-On-Biologics (2017-2027)
  1.5.1 Global Biosimilars-On-Biologics Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Biosimilars-On-Biologics Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Biosimilars-On-Biologics Market

2 INDUSTRY OUTLOOK

2.1 Biosimilars-On-Biologics Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Biosimilars-On-Biologics Market Drivers Analysis
2.4 Biosimilars-On-Biologics Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Biosimilars-On-Biologics Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Biosimilars-On-Biologics Industry Development

3 GLOBAL BIOSIMILARS-ON-BIOLOGICS MARKET LANDSCAPE BY PLAYER

3.1 Global Biosimilars-On-Biologics Sales Volume and Share by Player (2017-2022)
3.2 Global Biosimilars-On-Biologics Revenue and Market Share by Player (2017-2022)
3.3 Global Biosimilars-On-Biologics Average Price by Player (2017-2022)
3.4 Global Biosimilars-On-Biologics Gross Margin by Player (2017-2022)
3.5 Biosimilars-On-Biologics Market Competitive Situation and Trends
  3.5.1 Biosimilars-On-Biologics Market Concentration Rate
  3.5.2 Biosimilars-On-Biologics Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL BIOSIMILARS-ON-BIOLOGICS SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Biosimilars-On-Biologics Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Biosimilars-On-Biologics Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Biosimilars-On-Biologics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Biosimilars-On-Biologics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Biosimilars-On-Biologics Market Under COVID-19
4.5 Europe Biosimilars-On-Biologics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Biosimilars-On-Biologics Market Under COVID-19
4.6 China Biosimilars-On-Biologics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Biosimilars-On-Biologics Market Under COVID-19
4.7 Japan Biosimilars-On-Biologics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Biosimilars-On-Biologics Market Under COVID-19
4.8 India Biosimilars-On-Biologics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Biosimilars-On-Biologics Market Under COVID-19
4.9 Southeast Asia Biosimilars-On-Biologics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Biosimilars-On-Biologics Market Under COVID-19
4.10 Latin America Biosimilars-On-Biologics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Biosimilars-On-Biologics Market Under COVID-19
4.11 Middle East and Africa Biosimilars-On-Biologics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Biosimilars-On-Biologics Market Under COVID-19

5 GLOBAL BIOSIMILARS-ON-BIOLOGICS SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Biosimilars-On-Biologics Sales Volume and Market Share by Type (2017-2022)
5.2 Global Biosimilars-On-Biologics Revenue and Market Share by Type (2017-2022)
5.3 Global Biosimilars-On-Biologics Price by Type (2017-2022)
5.4 Global Biosimilars-On-Biologics Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Biosimilars-On-Biologics Sales Volume, Revenue and Growth Rate of Human growth hormone (2017-2022)
  5.4.2 Global Biosimilars-On-Biologics Sales Volume, Revenue and Growth Rate of Erythropoietin (2017-2022)
  5.4.3 Global Biosimilars-On-Biologics Sales Volume, Revenue and Growth Rate of Monoclonal antibodies (2017-2022)
  5.4.4 Global Biosimilars-On-Biologics Sales Volume, Revenue and Growth Rate of Insulin (2017-2022)
  5.4.5 Global Biosimilars-On-Biologics Sales Volume, Revenue and Growth Rate of Interferon (2017-2022)
  5.4.6 Global Biosimilars-On-Biologics Sales Volume, Revenue and Growth Rate of Granulocyte-Colony Stimulating Factor (2017-2022)
  5.4.7 Global Biosimilars-On-Biologics Sales Volume, Revenue and Growth Rate of Peptide (2017-2022)

6 GLOBAL BIOSIMILARS-ON-BIOLOGICS MARKET ANALYSIS BY APPLICATION

6.1 Global Biosimilars-On-Biologics Consumption and Market Share by Application (2017-2022)
6.2 Global Biosimilars-On-Biologics Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Biosimilars-On-Biologics Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Biosimilars-On-Biologics Consumption and Growth Rate of Blood disorders (2017-2022)
  6.3.2 Global Biosimilars-On-Biologics Consumption and Growth Rate of Oncology diseases (2017-2022)
  6.3.3 Global Biosimilars-On-Biologics Consumption and Growth Rate of Chronic and autoimmune diseases (2017-2022)
  6.3.4 Global Biosimilars-On-Biologics Consumption and Growth Rate of Growth hormone deficiencies (2017-2022)

7 GLOBAL BIOSIMILARS-ON-BIOLOGICS MARKET FORECAST (2022-2027)

7.1 Global Biosimilars-On-Biologics Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Biosimilars-On-Biologics Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Biosimilars-On-Biologics Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Biosimilars-On-Biologics Price and Trend Forecast (2022-2027)
7.2 Global Biosimilars-On-Biologics Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Biosimilars-On-Biologics Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Biosimilars-On-Biologics Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Biosimilars-On-Biologics Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Biosimilars-On-Biologics Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Biosimilars-On-Biologics Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Biosimilars-On-Biologics Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Biosimilars-On-Biologics Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Biosimilars-On-Biologics Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Biosimilars-On-Biologics Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Biosimilars-On-Biologics Revenue and Growth Rate of Human growth hormone (2022-2027)
  7.3.2 Global Biosimilars-On-Biologics Revenue and Growth Rate of Erythropoietin (2022-2027)
  7.3.3 Global Biosimilars-On-Biologics Revenue and Growth Rate of Monoclonal antibodies (2022-2027)
  7.3.4 Global Biosimilars-On-Biologics Revenue and Growth Rate of Insulin (2022-2027)
  7.3.5 Global Biosimilars-On-Biologics Revenue and Growth Rate of Interferon (2022-2027)
  7.3.6 Global Biosimilars-On-Biologics Revenue and Growth Rate of Granulocyte-Colony Stimulating Factor (2022-2027)
  7.3.7 Global Biosimilars-On-Biologics Revenue and Growth Rate of Peptide (2022-2027)
7.4 Global Biosimilars-On-Biologics Consumption Forecast by Application (2022-2027)
  7.4.1 Global Biosimilars-On-Biologics Consumption Value and Growth Rate of Blood disorders(2022-2027)
  7.4.2 Global Biosimilars-On-Biologics Consumption Value and Growth Rate of Oncology diseases(2022-2027)
  7.4.3 Global Biosimilars-On-Biologics Consumption Value and Growth Rate of Chronic and autoimmune diseases(2022-2027)
  7.4.4 Global Biosimilars-On-Biologics Consumption Value and Growth Rate of Growth hormone deficiencies(2022-2027)
7.5 Biosimilars-On-Biologics Market Forecast Under COVID-19

8 BIOSIMILARS-ON-BIOLOGICS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Biosimilars-On-Biologics Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Biosimilars-On-Biologics Analysis
8.6 Major Downstream Buyers of Biosimilars-On-Biologics Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Biosimilars-On-Biologics Industry

9 PLAYERS PROFILES

9.1 Biogen idec Inc.
  9.1.1 Biogen idec Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Biosimilars-On-Biologics Product Profiles, Application and Specification
  9.1.3 Biogen idec Inc. Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Teva Pharmaceutical Industries Ltd.
  9.2.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Biosimilars-On-Biologics Product Profiles, Application and Specification
  9.2.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 LG Life Sciences
  9.3.1 LG Life Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Biosimilars-On-Biologics Product Profiles, Application and Specification
  9.3.3 LG Life Sciences Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Synthon Pharmaceuticals, Inc.
  9.4.1 Synthon Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Biosimilars-On-Biologics Product Profiles, Application and Specification
  9.4.3 Synthon Pharmaceuticals, Inc. Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Novartis
  9.5.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Biosimilars-On-Biologics Product Profiles, Application and Specification
  9.5.3 Novartis Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Hospira
  9.6.1 Hospira Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Biosimilars-On-Biologics Product Profiles, Application and Specification
  9.6.3 Hospira Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Merck Serono
  9.7.1 Merck Serono Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Biosimilars-On-Biologics Product Profiles, Application and Specification
  9.7.3 Merck Serono Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Celltrion
  9.8.1 Celltrion Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Biosimilars-On-Biologics Product Profiles, Application and Specification
  9.8.3 Celltrion Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Biocon
  9.9.1 Biocon Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Biosimilars-On-Biologics Product Profiles, Application and Specification
  9.9.3 Biocon Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION


11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES




Figure Biosimilars-On-Biologics Product Picture

Table Global Biosimilars-On-Biologics Market Sales Volume and CAGR (%) Comparison by Type

Table Biosimilars-On-Biologics Market Consumption (Sales Volume) Comparison by Application (2017-2027)

Figure Global Biosimilars-On-Biologics Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)

Figure United States Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Europe Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure China Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Japan Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure India Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Southeast Asia Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Latin America Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Middle East and Africa Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Global Biosimilars-On-Biologics Market Sales Volume Status and Outlook (2017-2027)

Table Global Macroeconomic Analysis

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Biosimilars-On-Biologics Industry Development

Table Global Biosimilars-On-Biologics Sales Volume by Player (2017-2022)

Table Global Biosimilars-On-Biologics Sales Volume Share by Player (2017-2022)

Figure Global Biosimilars-On-Biologics Sales Volume Share by Player in 2021

Table Biosimilars-On-Biologics Revenue (Million USD) by Player (2017-2022)

Table Biosimilars-On-Biologics Revenue Market Share by Player (2017-2022)

Table Biosimilars-On-Biologics Price by Player (2017-2022)

Table Biosimilars-On-Biologics Gross Margin by Player (2017-2022)

Table Mergers & Acquisitions, Expansion Plans

Table Global Biosimilars-On-Biologics Sales Volume, Region Wise (2017-2022)

Table Global Biosimilars-On-Biologics Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Biosimilars-On-Biologics Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Biosimilars-On-Biologics Sales Volume Market Share, Region Wise in 2021

Table Global Biosimilars-On-Biologics Revenue (Million USD), Region Wise (2017-2022)

Table Global Biosimilars-On-Biologics Revenue Market Share, Region Wise (2017-2022)

Figure Global Biosimilars-On-Biologics Revenue Market Share, Region Wise (2017-2022)

Figure Global Biosimilars-On-Biologics Revenue Market Share, Region Wise in 2021

Table Global Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table United States Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Europe Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table China Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Japan Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table India Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Southeast Asia Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Latin America Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Middle East and Africa Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Global Biosimilars-On-Biologics Sales Volume by Type (2017-2022)

Table Global Biosimilars-On-Biologics Sales Volume Market Share by Type (2017-2022)

Figure Global Biosimilars-On-Biologics Sales Volume Market Share by Type in 2021

Table Global Biosimilars-On-Biologics Revenue (Million USD) by Type (2017-2022)

Table Global Biosimilars-On-Biologics Revenue Market Share by Type (2017-2022)

Figure Global Biosimilars-On-Biologics Revenue Market Share by Type in 2021

Table Biosimilars-On-Biologics Price by Type (2017-2022)

Figure Global Biosimilars-On-Biologics Sales Volume and Growth Rate of Human growth hormone (2017-2022)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Human growth hormone (2017-2022)
Figure Global Biosimilars-On-Biologics Sales Volume and Growth Rate of Erythropoietin (2017-2022)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Erythropoietin (2017-2022)
Figure Global Biosimilars-On-Biologics Sales Volume and Growth Rate of Monoclonal antibodies (2017-2022)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Monoclonal antibodies (2017-2022)
Figure Global Biosimilars-On-Biologics Sales Volume and Growth Rate of Insulin (2017-2022)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Insulin (2017-2022)
Figure Global Biosimilars-On-Biologics Sales Volume and Growth Rate of Interferon (2017-2022)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Interferon (2017-2022)
Figure Global Biosimilars-On-Biologics Sales Volume and Growth Rate of Granulocyte-Colony Stimulating Factor (2017-2022)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (2017-2022)
Figure Global Biosimilars-On-Biologics Sales Volume and Growth Rate of Peptide (2017-2022)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Peptide (2017-2022)
Table Global Biosimilars-On-Biologics Consumption by Application (2017-2022)

Table Global Biosimilars-On-Biologics Consumption Market Share by Application (2017-2022)

Table Global Biosimilars-On-Biologics Consumption Revenue (Million USD) by Application (2017-2022)

Table Global Biosimilars-On-Biologics Consumption Revenue Market Share by Application (2017-2022)

Table Global Biosimilars-On-Biologics Consumption and Growth Rate of Blood disorders (2017-2022)
Table Global Biosimilars-On-Biologics Consumption and Growth Rate of Oncology diseases (2017-2022)
Table Global Biosimilars-On-Biologics Consumption and Growth Rate of Chronic and autoimmune diseases (2017-2022)
Table Global Biosimilars-On-Biologics Consumption and Growth Rate of Growth hormone deficiencies (2017-2022)
Figure Global Biosimilars-On-Biologics Sales Volume and Growth Rate Forecast (2022-2027)

Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate Forecast (2022-2027)

Figure Global Biosimilars-On-Biologics Price and Trend Forecast (2022-2027)

Figure USA Biosimilars-On-Biologics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure USA Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Biosimilars-On-Biologics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure China Biosimilars-On-Biologics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure China Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Biosimilars-On-Biologics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure India Biosimilars-On-Biologics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure India Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Biosimilars-On-Biologics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Biosimilars-On-Biologics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Biosimilars-On-Biologics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Biosimilars-On-Biologics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Table Global Biosimilars-On-Biologics Market Sales Volume Forecast, by Type

Table Global Biosimilars-On-Biologics Sales Volume Market Share Forecast, by Type

Table Global Biosimilars-On-Biologics Market Revenue (Million USD) Forecast, by Type

Table Global Biosimilars-On-Biologics Revenue Market Share Forecast, by Type

Table Global Biosimilars-On-Biologics Price Forecast, by Type

Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Human growth hormone (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Human growth hormone (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Erythropoietin (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Erythropoietin (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Monoclonal antibodies (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Monoclonal antibodies (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Insulin (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Insulin (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Interferon (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Interferon (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Peptide (2022-2027)
Figure Global Biosimilars-On-Biologics Revenue (Million USD) and Growth Rate of Peptide (2022-2027)
Table Global Biosimilars-On-Biologics Market Consumption Forecast, by Application

Table Global Biosimilars-On-Biologics Consumption Market Share Forecast, by Application

Table Global Biosimilars-On-Biologics Market Revenue (Million USD) Forecast, by Application

Table Global Biosimilars-On-Biologics Revenue Market Share Forecast, by Application

Figure Global Biosimilars-On-Biologics Consumption Value (Million USD) and Growth Rate of Blood disorders (2022-2027)
Figure Global Biosimilars-On-Biologics Consumption Value (Million USD) and Growth Rate of Oncology diseases (2022-2027)
Figure Global Biosimilars-On-Biologics Consumption Value (Million USD) and Growth Rate of Chronic and autoimmune diseases (2022-2027)
Figure Global Biosimilars-On-Biologics Consumption Value (Million USD) and Growth Rate of Growth hormone deficiencies (2022-2027)
Figure Biosimilars-On-Biologics Industrial Chain Analysis

Table Key Raw Materials Suppliers and Price Analysis

Figure Manufacturing Cost Structure Analysis

Table Alternative Product Analysis

Table Downstream Distributors

Table Downstream Buyers

Table Biogen idec Inc. Profile
Table Biogen idec Inc. Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biogen idec Inc. Biosimilars-On-Biologics Sales Volume and Growth Rate
Figure Biogen idec Inc. Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Biosimilars-On-Biologics Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table LG Life Sciences Profile
Table LG Life Sciences Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure LG Life Sciences Biosimilars-On-Biologics Sales Volume and Growth Rate
Figure LG Life Sciences Revenue (Million USD) Market Share 2017-2022
Table Synthon Pharmaceuticals, Inc. Profile
Table Synthon Pharmaceuticals, Inc. Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Synthon Pharmaceuticals, Inc. Biosimilars-On-Biologics Sales Volume and Growth Rate
Figure Synthon Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Biosimilars-On-Biologics Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table Hospira Profile
Table Hospira Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Hospira Biosimilars-On-Biologics Sales Volume and Growth Rate
Figure Hospira Revenue (Million USD) Market Share 2017-2022
Table Merck Serono Profile
Table Merck Serono Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Serono Biosimilars-On-Biologics Sales Volume and Growth Rate
Figure Merck Serono Revenue (Million USD) Market Share 2017-2022
Table Celltrion Profile
Table Celltrion Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celltrion Biosimilars-On-Biologics Sales Volume and Growth Rate
Figure Celltrion Revenue (Million USD) Market Share 2017-2022
Table Biocon Profile
Table Biocon Biosimilars-On-Biologics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biocon Biosimilars-On-Biologics Sales Volume and Growth Rate
Figure Biocon Revenue (Million USD) Market Share 2017-2022






More Publications